कोशिश गोल्ड - मुक्त
Ex-Fed governor Adriana Kugler resigned after violating trading rules
Mint Chennai
|November 17, 2025
Kugler stepped down in early August—nearly six months before her term was set to end
Newly released documents showed previously undisclosed trading by Kugler in 2024 in individual stocks
Former US Federal Reserve (Fed) governor Adriana Kugler, whose abrupt resignation allowed President Donald Trump to install an ally at the US central bank, violated Fed ethics rules and was subject to an internal probe when she stepped down in August, documents released Saturday showed.
In her final weeks at the Fed, Kugler sought to address a problem with her financial holdings, but chair Jerome Powell denied her request for a necessary waiver ahead of the central bank’s 29-30 July policy meeting, according to a Fed official. She skipped the meeting and announced her resignation days later.
The Office of Government Ethics on Saturday released Kugler’s latest financial disclosures, which included previously undisclosed trading in multiple individual stocks in 2024—some of which occurred during the Fed's blackout period—in violation of the agency's ethics rules.
Fed ethics officials referred the matter to the agency’s inspector general (IG) earlier this year, the form showed. They also declined to certify the disclosures, which Kugler filed about a month after her resignation. An IG spokesperson said Saturday that an investigation is ongoing.
Kugler’s resignation gave Trump an earlier-than-expected opportunity to fill a slot on the Fed’s board in the midst of his intense pressure campaign urging policymakers to drastically lower interest rates. The opening ultimately went to Trump adviser Stephen Miran, who took an unpaid leave of absence from his post as chair of the White House Council of Economic Advisers and has called repeatedly for rapid rate cuts.
यह कहानी Mint Chennai के November 17, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Chennai से और कहानियाँ
Mint Chennai
India's first class action hits snag as lead petitioner exits
Lead shareholder Ankit Jain has sought to exit the class action suit against Jindal Poly Films
2 mins
April 10, 2026
Mint Chennai
Panel to assess health insurers’ concerns
In an effort to improve policyholder experience and penetration of health insurance in the country, the Insurance Regulatory and Development Authority of India (Irdai) has constituted a subcommittee of the Insurance Advisory Committee.
1 mins
April 10, 2026
Mint Chennai
From access to agency: Reset the goal for women's empowerment
Increased participation in the Indian economy isn't sufficient. Women should be empowered to shape our economic outcomes
3 mins
April 10, 2026
Mint Chennai
Why Iran thinks it won the war despite huge military losses
When Iran agreed to a two-week ceasefire only hours before President Trump had vowed to unleash punishing new attacks, it was in many ways a moment of triumph for the battered regime.
4 mins
April 10, 2026
Mint Chennai
Of food, art and a drag show
A Mint guide to what's happening in and around your city
1 min
April 10, 2026
Mint Chennai
Is the US-Israel-Iran ceasefire a pause or tactical turning point?
This conflict’s trajectory will depend on whether the adversaries can resolve its structural drivers
3 mins
April 10, 2026
Mint Chennai
LNG supply woes spur India's compressed biogas push
Govt to streamline initiatives aimed at promoting biogas.
1 mins
April 10, 2026
Mint Chennai
Phoenix offers cheaper retail proxy. Real estate is the risk
Shares of The Phoenix Mills Ltd have risen 7% in the past two sessions, buoyed by its Q4FY26 business update.
1 mins
April 10, 2026
Mint Chennai
SECOND LIFE: RMG OUTFITS TRY NEW PLAYING FIELDS
Six months after real-money gaming was banned, the industry is trying to reboot.
8 mins
April 10, 2026
Mint Chennai
Govt to bar private lab tests of vaccines, biological products
India plans to restrict the testing of vaccines and specialized biological products exclusively to government-controlled laboratories to maintain quality standards, according to two government officials and documents reviewed by Mint.
1 min
April 10, 2026
Listen
Translate
Change font size
